Canada Future Directions in IBD

 

Canada Future Directions in IBD is Crohn’s and Colitis Canada’s premier conference for healthcare professionals and researchers who care for patients with inflammatory bowel diseases (IBD) and carry out research into these disorders.

One of the goals of Canada Future Directions in IBD is to present the best new scientific research in IBD and advance knowledge on the state of the science. Crohn’s and Colitis Canada’s Promise Statement emphasizes our long-term commitment to finding cures for Crohn’s disease and ulcerative colitis as well as our commitment to undertakings that will have a more immediate impact on the lives of everyone affected by these chronic diseases. 

On November 6, Crohn’s and Colitis Canada will launch a national campaign in support of the upcoming IBD Precision Medicine Research Program during a special cocktail hour hosted alongside Meeting of the Minds. This milestone will mark the beginning of a long-term national effort to advance a new era in IBD care, bringing researchers, clinicians, donors, partners, government and media representatives, and community voices together around one shared goal: faster answers, more personalized treatment, and more time back for people living with Crohn’s disease and ulcerative colitis.

Our Promise: To cure Crohn’s disease and ulcerative colitis and improve the quality of life of everyone affected by these diseases.

Knowledge translation is important to delivering on our Promise. Now in its fourteenth year, the Canada Future Directions in IBD national symposium remains one of our key programs to translate what is learned in research into the hands of the practitioners treating IBD patients and to highlight the significant progress being made by our funded researchers.

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.